Clinical Trial

Tumor Antigen-sensitized DC Vaccine for Colorectal Cancer Liver Metastases

Unknown Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated August 9, 2024 (before its estimated November 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study is to explore the safety and efficacy of tumor antigen-sensitized DC vaccine in postoperative adjuvant treatment of R0 excision Colorectal Cancer Liver Metastases.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06545630
Lead Sponsor West China Hospital
Conditions Carcinoma, Colorectal Cancer
Enrollment 10 participants
Start Date 2023-11-01
Primary Completion 2025-11 (estimated)
Study Completion 2026-05 (estimated)
Updated on ClinicalTrials.gov 2024-08-09